'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
about
Mechanisms regulating endothelial permeabilityTurning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentSerine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behaviorNovel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.Differential signaling by protease-activated receptors: implications for therapeutic targeting.The G protein betagamma subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin.Role of G protein-coupled receptors in inflammation.Signal transduction by protease-activated receptorsRegulation of the protein C anticoagulant and antiinflammatory pathways.Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbationsCooperative signaling via transcription factors NF-κB and AP1/c-Fos mediates endothelial cell STIM1 expression and hyperpermeability in response to endotoxin.Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.Proteinase-activated receptors in fibroproliferative lung disease.Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5.Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection.Allosteric modulation of protease-activated receptor signaling.Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse plateletsInterdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducinsTargeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.Proteases display biased agonism at protease-activated receptors: location matters!Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function.Activated protein C: biased for translation.We can do it together: PAR1/PAR2 heterodimer signaling in VSMCsProtease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosisTargeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.The down regulation of neutrophil oxidative metabolism by S100A8 and S100A9: implication of the protease-activated receptor-2Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsMapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis.Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation.Interface between hemostasis and adaptive immunityTransient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability.Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombinMatrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells.Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.Matrix metalloproteases and PAR1 activation.
P2860
Q26866511-A05DA83A-1E95-4734-BCB5-6D8BCB38ED02Q27024397-DF25E369-A216-4D71-9746-E0E5631EDFDDQ28741929-43F56CB4-35D2-4F10-BE55-7FF7A19B69C0Q33498642-82209884-2C5E-4ABD-BF4F-05E38B9CD811Q33580620-FEB8ED87-741D-4D4C-9174-1DB7F2DB03D7Q33591096-D3E03A3E-DE89-4D7C-B943-B233E1E6914FQ33858841-5F3540D1-5A55-493E-BAF0-4590168E87BFQ33870369-E1B8796F-792A-4281-B827-CA133FCD4667Q33996371-EA7FEDC4-6224-45FA-B435-0BB5B7A7F80EQ34048965-4C1F2085-2112-43A4-BC04-6A7981F2700BQ34062965-64B6E360-9BB9-4A63-8149-241C7592BB8FQ34107201-E44D66B1-4DC2-43B8-B351-D13776EECC82Q34148307-76AF4C43-A561-4F4B-99B3-EC71681A0D7AQ34382241-3FC987DF-A084-46A6-A37E-A92823BFB6D3Q34450747-17E34176-D9A6-44F5-808E-9389A0068BC7Q34463502-95BBCFE7-823E-46E7-81F7-8744209AA2E8Q34475362-7B0DE5F0-A359-4805-A6F8-D0668FC033D8Q34543233-6E888B8C-B200-4FD1-B6E9-2F34AAF302C1Q34580126-C159E95E-973B-42E2-8BBF-9FF4E01CD7F1Q34584466-C8DE82EC-8A9E-492B-B958-63514A2F254AQ35002854-691F61AD-1FA9-48B1-8538-BDAA1B04DE95Q35070124-AF037D80-5DD9-428E-93BE-9568B8D742D4Q35114471-C77037EB-D23C-49CC-B1F2-2EA4EDA96C3CQ35544489-854456B1-CD63-43F3-A810-668661CC1115Q35583397-15FAC705-3339-45AC-B915-160C74701C88Q35599925-CFA25DAF-34A0-4185-939B-CD4DF9643C2FQ35620514-F5A58EFB-E8D0-4BDA-849E-B52F4CD2E716Q35695573-7809DB35-D1A6-4305-AD5E-467C42DCEBBFQ35776992-F7F45E87-AB17-49E7-B7C2-3FBD01E331DAQ35785544-AE3A1403-7012-4E9E-8D16-925F1E4DD2CFQ35860717-45EC1FA5-7848-4FA8-A960-ED9FBFD0D035Q35879995-CB64E923-C64E-4F22-8F57-E682A5743372Q36088900-8C55331F-900F-4B56-A534-30B8EF82BB59Q36164146-F38032A1-1CD0-4645-821D-8DE276914AD1Q36190599-DB882DDD-46B7-4067-9D8E-6C8667142321Q36385420-22064160-CD33-4BBD-8398-A5A372FA59CBQ36478416-29BF620A-69A2-4B77-8384-8F0D38F99059Q36508733-3F20EB2B-9673-4740-924F-40EFD661FC6FQ36509665-5634CC97-A78A-4A18-B87A-117BA9F686A8Q36542806-0AF3AEDA-2BA1-47FD-BB50-9788BE5F4478
P2860
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@ast
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@en
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@nl
type
label
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@ast
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@en
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@nl
prefLabel
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@ast
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@en
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@nl
P2093
P2860
P356
P1433
P1476
'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
@en
P2093
Andrew J Leger
Anika Agarwal
Athan Kuliopulos
Claudia Derian
George Perides
Lidija Covic
Nga Nguyen
Nicole C Kaneider
P2860
P304
P356
10.1038/NI1525
P407
P577
2007-10-28T00:00:00Z